Cardiac MR of Subclinical CVD: Impact of Age

NCT00041418 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-07-29

No results posted yet for this study

Summary

To use magnetic resonance imaging to identify subclinical atherosclerosis and left ventricular hypertrophy in the Framingham Heart Study cohort.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Warren Manning · Beth Israel Deaconess Medical Center

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2006-08-31
Completion
2006-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00041418 on ClinicalTrials.gov